Literature DB >> 19152082

Current progress in epigenetic research for hepatocarcinomagenesis.

Jian Huang1.   

Abstract

Hepatocellular carcinoma is the main type of primary liver cancer, and also one of the most malignant tumors. At present, the pathogenesis mechanisms of liver cancer are not entirely clear. It has been shown that inactivation of tumor suppressor genes and activation of oncogenes play a significant role in carcinogenesis, caused by the genetic and epigenetic aberrance. In the past, people generally thought that genetic mutation is a key event of tumor pathogenesis, and somatic mutation of tumor suppressor genes is in particular closely associated with oncogenesis. With deeper understanding of tumors in recent years, increasing evidence has shown that epigenetic silencing of those genes, as a result of aberrant hypermethylation of CpG islands in promoters and histone modification, is essential to carcinogenesis and metastasis. The term epigenetics refers to heritable changes in gene expression caused by regulation mechanisms, other than changes in the underlying DNA sequence. Specific epigenetic processes include DNA methylation, genome imprinting, chromotin remodeling, histone modification and microRNA regulations. This paper reviews recent epigenetics research progress in the hepatocellular carcinoma study, and tries to depict the relationships between hepatocellular carcinomagenesis and DNA methylation as well as microRNA regulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19152082     DOI: 10.1007/s11427-009-0014-7

Source DB:  PubMed          Journal:  Sci China C Life Sci        ISSN: 1006-9305


  15 in total

1.  MiR-146a suppresses hepatocellular carcinoma by downregulating TRAF6.

Authors:  Yong Zu; Yanhong Yang; Jiyun Zhu; Xiaobo Bo; Shuangxing Hou; Bo Zhang; Jiangfeng Qiu; Jing Zheng
Journal:  Am J Cancer Res       Date:  2016-11-01       Impact factor: 6.166

2.  Frequent and distinct aberrations of DNA methylation patterns in fibrolamellar carcinoma of the liver.

Authors:  Wolfgang Tränkenschuh; Florian Puls; Matthias Christgen; Cord Albat; Albert Heim; Jeanette Poczkaj; Peer Fleming; Hans Kreipe; Ulrich Lehmann
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

3.  Downregulation of KIF1B mRNA in hepatocellular carcinoma tissues correlates with poor prognosis.

Authors:  Song-Zhu Yang; Jian-Tao Wang; Wei-Wei Yu; Qing Liu; Yan-Fang Wu; Shu-Guang Chen
Journal:  World J Gastroenterol       Date:  2015-07-21       Impact factor: 5.742

4.  A comprehensive analysis of the dynamic biological networks in HCV induced hepatocarcinogenesis.

Authors:  Bing He; Hao Zhang; Tieliu Shi
Journal:  PLoS One       Date:  2011-04-19       Impact factor: 3.240

5.  From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms.

Authors:  Marion Martin; Zdenko Herceg
Journal:  Genome Med       Date:  2012-01-31       Impact factor: 11.117

6.  MicroRNA-377 suppresses cell proliferation and invasion by inhibiting TIAM1 expression in hepatocellular carcinoma.

Authors:  Guolin Chen; Lu Lu; Chang Liu; Lei Shan; Di Yuan
Journal:  PLoS One       Date:  2015-03-04       Impact factor: 3.240

7.  The tumor-suppressive microRNA-135b targets c-myc in osteoscarcoma.

Authors:  Zheng Liu; Guangwu Zhang; Jian Li; Jiabang Liu; Pengfeng Lv
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

8.  miR-211 suppresses hepatocellular carcinoma by downregulating SATB2.

Authors:  Guixing Jiang; Yunfu Cui; Xin Yu; Zhengrong Wu; Guoping Ding; Liping Cao
Journal:  Oncotarget       Date:  2015-04-20

9.  MicroRNA-150 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting the GAB1-ERK axis.

Authors:  Wei Sun; Zhuochao Zhang; Jianlin Wang; Runze Shang; Liang Zhou; Xing Wang; Juanli Duan; Bai Ruan; Yuan Gao; Bin Dai; Shibin Qu; Wei Liu; Rui Ding; Lin Wang; Desheng Wang; Kefeng Dou
Journal:  Oncotarget       Date:  2016-03-08

10.  Prognostic Model for the Risk Stratification of Early and Late Recurrence in Hepatitis B Virus-Related Small Hepatocellular Carcinoma Patients with Global Histone Modifications.

Authors:  Jin-Ling Duan; Run-Cong Nie; Zhi-Cheng Xiang; Jie-Wei Chen; Min-Hua Deng; Hu Liang; Feng-Wei Wang; Rong-Zhen Luo; Dan Xie; Mu-Yan Cai
Journal:  J Hepatocell Carcinoma       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.